Results 241 to 250 of about 180,219 (298)

Study on the expression characteristics of CA125 in patients with SLE and its correlation with clinical indicators. [PDF]

Medicine (Baltimore)
Xu S, Guo X, Lu T, Zhang C.
europepmc   +1 more source

Treatment of HRD-positive elderly ovarian cancer patient: a case report. [PDF]

Anticancer Drugs
Jiang Y, Yi Q, Wang Y, Li C, Liu H.
europepmc   +1 more source

Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) in Pancreatic Adenocarcinoma. [PDF]

Int J Mol Sci
Dima AC, Balaban DV, Stanescu-Spinu II, Teodorescu A, Manucu G, Coman LI, Dima A, Betianu C, Tanase M, Miricescu D, Jinga M, Carstoiu C.   +11 more
europepmc   +1 more source

2[18F]-FDG-PET/CT and 2[18F]-FDG-PET/MRI in primary staging of epithelial ovarian cancer - an early interim analysis of a prospective clinical trial. [PDF]

Ann Med Surg (Lond)
Rosendahl K, Båtsman M, Ottander U, Strandberg SN.   +3 more
europepmc   +1 more source

Squamous cell carcinoma arising within a mature cystic teratoma of the ovary in a postmenopausal woman: A case report and literature review. [PDF]

Case Rep Womens Health
Bahall V, Bhagaloo V, De Barry L, Nidhan N, Harrygin S, Rampersad A.   +5 more
europepmc   +1 more source

Identifying the best diagnostic test for ovarian cancer - synopsis of Refining Ovarian Cancer Test accuracy Scores (ROCkeTS) research.

Health Technol Assess
Sundar S, Agarwal R, Scandrett K, Davenport C, Sturdy L, Ottridge R, Deeks J, ROCkeTS collaborators.   +7 more
europepmc   +1 more source

The CA 125 tumour-associated antigen: a review of the literature

Human Reproduction, 1989
CA 125 is an antigenic determinant on a high-molecular-weight glycoprotein recognized by a monoclonal antibody which was raised using an ovarian cancer cell line as an immunogen. During the last 5 years the studies reviewed in this paper have provided information concerning the nature, distribution and clinical significance of CA 125.
Jacobs, I., Bast, R. C.
core   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Serum CA-125 antigen levels increase during menses

American Journal of Obstetrics and Gynecology, 1987
Serum CA-125 antigen levels were measured by radioimmunoassay before and during menses in women with and without endometriosis. Mean CA-125 levels were significantly increased in both groups during menses. Samples obtained during menses represent a potential source of elevated levels and false positive results.
Donald E Pittaway, Jamil A Fayez, J A Fayez   +2 more
exaly   +3 more sources

CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases

Clinica Chimica Acta, 1986
The presence of Ca 125, an ovarian cancer-associated antigen, was assessed in serum from patients with liver diseases with (n = 26) and without (n = 26) ascites. Abnormal levels of serum CA 125 were observed in all patients with ascites and in 4 patients without ascites (15%).
J M Bidart, C Bohuon
exaly   +3 more sources

Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer

Gynecologic Oncology, 2006
Objective. The relationship between survival and early changes in the serum level of the CA-125 antigen in patients with advanced ovarian cancer remains poorly defined. Methods.
Maurie Markman, Massimo Federico, P Y Liu   +2 more
exaly   +2 more sources